Women with an HbA1c of 41–49 mmol/mol (5.9–6.6%): a higher risk subgroup that may benefit from early pregnancy intervention
posted by WM Admin on 16 June 2015
Year of Publication
Diabetic Medicine, 15 June [Epub before print]
Journal article (peer reviewed)
In this observational study of women with gestational diabetes diagnosed by early HbA1c screening or subsequent oral glucose tolerance test at < 34 weeks' gestation who delivered at National Women's Health, Auckland, from July 2012 to June 2014, the authors concluded that "an HbA1c of 41–49 mmol/mol (5.9–6.7%) identifies a higher-risk group of women with gestational diabetes. Overall, our data support early treatment of women with an HbA1c ≥ 41 mmol/mol (5.9%)".
How to Access
To read the full abstract, and for information on how to access the full text, go to: http://dx.doi.org/10.1111/dme.12812 or contact your DHB library, or organisational or local library for assistance.